NCT01492218
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Manila, Philippines
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
7,998 public trials
712 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00871416
- Conditions
- Autoimmune Diseases, Delivery Systems, Diabetes, +8 more
- Locations
-
- Novo Nordisk Investigational Site Aarhus, Denmark
NCT01426802
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Investigative site Cairo, Egypt
NCT00494884
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Investigative Site Bochum, Germany
Completed
Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes
NCT01497522
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Investigative Site Fukuoka, Japan
- Novartis Investigative Site Fukuoka, Japan
- Novartis Investigative Site Kitakyushu, Fukuoka, Japan
- Novartis Investigative Site Kurume, Fukuoka, Japan
NCT01518101
- Conditions
- Behavior, Diabetes Mellitus, Diabetes Mellitus, Type 2, +9 more
- Locations
-
- Novartis Investigative Site Völlkingen, Germany
- Novartis Investigative Site Berlin, Germany
- Novartis Investigative Site Berlin, Germany
- Novartis Investigative Site Dortmund, Germany
Completed
Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects
NCT01572753
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
- Locations
-
- Novo Nordisk Investigational Site Berlin, Germany
NCT01467375
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Broadmeadow, New South Wales, Australia
- Novo Nordisk Investigational Site Parkville, Victoria, Australia
- Novo Nordisk Investigational Site Ashford, Australia
- Novo Nordisk Investigational Site Auchenflower, Australia
NCT01650129
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
NCT01519674
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Buenos Aires, Argentina
- Novo Nordisk Investigational Site Buenos Aires, Argentina
- Novo Nordisk Investigational Site Caba, Argentina
- Novo Nordisk Investigational Site Caba, Argentina